Skip to search boxSkip to navigationSkip to main content

Role of menkes ATpase in angiotensin II-induced hypertension: A key modulator for extracellular superoxide dismutase function

  • Zhenyu Qin
    ,
  • Maria Carolina Gongora
    ,
  • Kiyoshi Ozumi
    ,
  • Shinichi Itoh
    ,
  • Kamran Akram
    ,
*Corresponding author for this work
  • Emory University
    ,
  • Department of Medicine (Section of Cardiology)
    ,
  • University of Illinois at Chicago
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

The extracellular superoxide dismutase (SOD3), a secretory copper-containing enzyme, regulates angiotensin II (Ang II)-induced hypertension by modulating levels of extracellular superoxide anion. The present study was designed to determine the role of the copper transporter Menkes ATPase (MNK) in Ang II-induced SOD3 activity and hypertension in vivo. Here we show that chronic Ang II infusion enhanced systolic blood pressure and vascular superoxide anion production in MNK mutant (MNKmut) mice as compared with those in wild-type mice, which are associated with impaired acetylcholine-induced endothelium-dependent vasorelaxation in MNKmut mice. These effects in MNKmut mice are rescued by infusion of the SOD mimetic Tempol. By contrast, norepinephrine-induced hypertension, which is not associated with an increase in vascular superoxide anion production, is not affected in MNK mut mice. Mechanistically, basal and Ang II infusion-induced increase in vascular SOD3-specific activity is significantly inhibited in MNK mut mice. Coimmunoprecipitation analysis reveals that Ang II stimulation promotes association of MNK with SOD3 in cultured vascular smooth muscle cell and in mouse aortas, which may contribute to SOD3-specific activity by increasing copper delivery to SOD3 through MNK. In summary, MNK plays an important role in modulating Ang II-induced hypertension and endothelial function by regulating SOD3 activity and vascular superoxide anion production and becomes a potential therapeutic target for oxidant stress-dependent cardiovascular diseases.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 945-951 (7 pages)

Journal (Volume, Issue Number)

Hypertension (Volume 52, Issue 5)

Publication milestones

  • Published - 11/2008

Publication status

Published - 11/2008

ISSN

0194-911X

Publication IDs

  • Scopus: 55949083662
  • PubMed: 18768397

Publication metrics

Metrics

Fractional count
2
Fractional count
0.25
Fractional count
6
Fractional count
0.75
Fractional count
2
Fractional count
1
SciVal
FWCI
1.59
SciVal
Author count
8
SciVal
citations
43
SciVal
Paper percentile
87
Scopus
citations

PlumX, opens in new tab

Citation count
50
Captures
25

Funding Details

FunderFunding number
NHLBI
P01HL058000